Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF -mutant metastatic melanoma: a real-world propensity score–matched survival analysis. - Garitaonaindia, Yago; Khan, Shawez; Friis, Rasmus; Kjær, Søren; Borch, Troels H; Ruhlmann, Christina; Guldbrandt, Louise M; Luczak, Adam A; Schmidt, Henrik; Bastholt, Lars (JNCI: Journal of the National Cancer Institute, 2026)